Products Categories
CAS No.: | 79-57-2 |
---|---|
Name: | Oxytetracycline |
Article Data: | 7 |
Cas Database | |
Molecular Structure: | |
|
|
Formula: | C22H24N2O9 |
Molecular Weight: | 460.441 |
Synonyms: | 2-Naphthacenecarboxamide,4-(dimethylamino)-1,4,4a,5,5a,6,11,12a-octahydro-3,5,6,10,12,12a-hexahydroxy-6-methyl-1,11-dioxo-(7CI,8CI);5-Hydroxytetracycline;Abbocin;Antibiotic TM 25;Biostat;2-Naphthacenecarboxamide,4-(dimethylamino)-1,4,4a,5,5a,6,11,12a-octahydro-3,5,6,10,12,12a-hexahydroxy-6-methyl-1,11-dioxo-,(4S,4aR,5S,5aR,6S,12aS)-;Dabicycline;Geomycin;Geomycin (Streptomyces vimosus);Geotilin;LA 200;Lenocycline;Liquamycin LA 200;Mycoshield TMQTHC 20;NSC 9169;Oxiter 200;Oxitetracyclin;Oxycline;Oxydon;Oxylim;Oxymykoin;Oxysentin 100;Oxyterracin;Oxyterracine;Oxytetracycline amphoteric;Oxytetral;Ryomycin;Stevacin;Stevasin;Tarosin;Terrafungine;Terralon LA;Terramycin343;Terramycin Q 50;Tetran;Ursocyclin;Ursocycline;Vendarcin; |
EINECS: | 201-212-8 |
Density: | 1.71 g/cm3 |
Melting Point: | 183 °C |
Boiling Point: | 727.8 °C at 760 mmHg |
Flash Point: | 394 °C |
Solubility: | Slightly soluble in ethanol, very slightly soluble in water |
Appearance: | beige to light yellow crystalline powder |
Hazard Symbols: |
![]() ![]() |
Risk Codes: | 63-36/37/38 |
Safety: | 22-24/25-36/37/39-26 |
PSA: | 201.85000 |
LogP: | -0.54330 |
Conditions | Yield |
---|---|
With laccase from Trametes versicolor In water at 25℃; for 24h; pH=6; Catalytic behavior; Kinetics; Reagent/catalyst; pH-value; Enzymatic reaction; |
Conditions | Yield |
---|---|
With laccase from Pycnoporus sp. SYBC-L10; 2,2'-azino-bis(3-ethylbenzothiazoline-6-sulfonic acid) diammonium salt In aq. phosphate buffer at 25℃; for 0.0666667h; pH=6; Catalytic behavior; Reagent/catalyst; Temperature; pH-value; Enzymatic reaction; |
Conditions | Yield |
---|---|
With dmap In dichloromethane at 0 - 25℃; for 1.5h; | 72% |
Conditions | Yield |
---|---|
In ethanol for 0.05h; Mannich reaction; microwave irradiation; | 66% |
Conditions | Yield |
---|---|
In toluene byproducts: CO; a mixt. in toluene was stirred for about 90 min at 70°C; ppt. was filtered, washed with toluene, pptn. from CH3CN-diethyl ether; elem. anal.; | 60% |
Oxytetracycline
4-dedimethylamino-12a-deoxyterramycin
Conditions | Yield |
---|---|
With zinc In acetic acid at 28℃; for 96h; | 54% |
With acetic acid; zinc |
formaldehyd
Oxytetracycline
1-ethyl-6-fluoro-1,4-dihydro-4-oxo-7-(1-piperazinyl)-3-quinoline carboxylic acid
Conditions | Yield |
---|---|
In ethanol for 0.05h; Mannich reaction; microwave irradiation; | 43% |
Conditions | Yield |
---|---|
In ethanol for 0.05h; Mannich reaction; microwave irradiation; | 41% |
Conditions | Yield |
---|---|
In ethanol for 0.05h; Mannich reaction; microwave irradiation; | 41% |
Conditions | Yield |
---|---|
With hydrogenchloride In water at 75℃; for 2h; | A 23.2% B n/a C 7.7% D 33.1% |
The Oxytetracycline, with the CAS registry number 79-57-2, is also known as 5-Hydroxytetracycline. Its EINECS number is 201-212-8. This chemical's molecular formula is C22H24N2O9 and molecular weight is 460.43. What's more, its systematic name is (4S,4aR,5S,5aR,6S,12aS) -4-(dimethylamino)-3,5,6,10,11,12a-hexahydroxy -6-methyl-1,12-dioxo-1,4,4a,5,5a,6,12,12a-octahydrotetracene -2-carboxamide. Its classification codes are: (1)Agricultural Chemical; (2)Anti-Bacterial Agents; (3)Anti-Infective Agents; (4)Drug / Therapeutic Agent; (5)Germicide, bactericide, disinfectant; (6)Human Data; (7)Mutation data; (8)Reproductive Effect. It is a tetracycline analog isolated from the actinomycete streptomyces rimosus and used in a wide variety of clinical conditions. It should be sealed and stored in a cool and ventilated place. Moreover, it should be protected from oxides, heat and fire. Oxytetracycline is a broad spectrum antibiotic that is active against a wide variety of bacteria. It is still used to treat infections caused by chlamydia. It is used to treat acne, due to its activity against the bacteria on the skin that cause acne. Moreover, it is also used to treat flare-ups of chronic bronchitis, due to its activity against the bacteria usually responsible, Haemophilus influenzae. It may also be used to treat other rarer infections, such as those caused by a group of micro-organisms called rickettsiae.
Physical properties of Oxytetracycline are: (1)ACD/LogP: 0.57; (2)# of Rule of 5 Violations: 2; (3)ACD/LogD (pH 5.5): -0.71; (4)ACD/LogD (pH 7.4): -2.34; (5)ACD/BCF (pH 5.5): 1; (6)ACD/BCF (pH 7.4): 1; (7)ACD/KOC (pH 5.5): 2.55; (8)ACD/KOC (pH 7.4): 1; (9)#H bond acceptors: 11; (10)#H bond donors: 8; (11)#Freely Rotating Bonds: 8; (12)Polar Surface Area: 113.07 Å2; (13)Index of Refraction: 1.762; (14)Molar Refractivity: 110.6 cm3; (15)Molar Volume: 268.1 cm3; (16)Polarizability: 43.84×10-24cm3; (17)Surface Tension: 111.3 dyne/cm; (18)Density: 1.71 g/cm3; (19)Flash Point: 394 °C; (20)Enthalpy of Vaporization: 111.54 kJ/mol; (21)Boiling Point: 727.8 °C at 760 mmHg; (22)Vapour Pressure: 3.09E-22 mmHg at 25°C.
Preparation: it is derived by fermentation of Streptomyces rimosus (Streptomyces rimosus). You can get the product by drying the solid after adding calcium carbonate into the fermentation broth, followed by filtration.
When you are using this chemical, please be cautious about it as the following:
This chemical is irritating to respiratory system and skin. It has a possible risk of harm to the unborn child. In case of contact with eyes, you should rinse immediately with plenty of water and seek medical advice. You should not breathe dust. When using it, you must avoid contact with eyes and need wear suitable protective clothing, gloves and eye/face protection.
You can still convert the following datas into molecular structure:
(1)SMILES: O=C4\C2=C(/O)c1c(cccc1O)[C@](O)(C)[C@H]2[C@H](O)[C@@H]3[C@@]4(O)C(=O)/C(C(=O)[C@H]3N(C)C)=C(\O)N
(2)Std. InChI: InChI=1S/C22H24N2O9/c1-21(32)7-5-4-6-8(25)9(7)15(26)10-12(21)17(28)13-14(24(2)3)16(27)11(20(23)31)19(30)22(13,33)18(10)29/h4-6,12-14,17,25-26,28,31-33H,23H2,1-3H3/b20-11-/t12-,13-,14+,17+,21-,22+/m1/s1
(3)Std. InChIKey: FYDOORKXBWEKQM-GUQPPTOYSA-N
The toxicity data is as follows:
Organism | Test Type | Route | Reported Dose (Normalized Dose) | Effect | Source |
---|---|---|---|---|---|
dog | LDLo | intravenous | 220mg/kg (220mg/kg) | BEHAVIORAL: SOMNOLENCE (GENERAL DEPRESSED ACTIVITY) BEHAVIORAL: FOOD INTAKE (ANIMAL) LUNGS, THORAX, OR RESPIRATION: OTHER CHANGES | Antibiotics and Chemotherapy Vol. 3, Pg. 1015, 1953. |
guinea pig | LDLo | intraperitoneal | 2250mg/kg (2250mg/kg) | Antibiotiki. Vol. 20, Pg. 793, 1975. | |
infant | TDLo | parenteral | 136mg/kg (136mg/kg) | MUSCULOSKELETAL: CHANGES IN TEETH AND SUPPORTING STRUCTURES | Lancet. Vol. 1, Pg. 827, 1962. |
man | TDLo | oral | 114mg/kg/4D (114mg/kg) | BLOOD: HEMORRHAGE SKIN AND APPENDAGES (SKIN): "DERMATITIS, OTHER: AFTER SYSTEMIC EXPOSURE" | JAMA, Journal of the American Medical Association. Vol. 231, Pg. 734, 1975. |
mouse | LD50 | intraperitoneal | 5706mg/kg (5706mg/kg) | Antibiotiki. Vol. 20, Pg. 793, 1975. | |
mouse | LD50 | intravenous | 140mg/kg (140mg/kg) | Arzneimittel-Forschung. Drug Research. Vol. 5, Pg. 1, 1955. | |
mouse | LD50 | oral | 2240mg/kg (2240mg/kg) | Arzneimittel-Forschung. Drug Research. Vol. 5, Pg. 1, 1955. | |
mouse | LD50 | subcutaneous | 700mg/kg (700mg/kg) | "CRC Handbook of Antibiotic Compounds," Vols.1- , Berdy, J., Boca Raton, FL, CRC Press, 1980Vol. 3, Pg. 44, 1980. | |
rat | LD50 | intravenous | 260mg/kg (260mg/kg) | "Antibiotics: Origin, Nature, and Properties," Korzyoski, T., et al., eds., Washington, DC, American Soc. for Microbiology, 1978Vol. 1, Pg. 501, 1978. | |
rat | LD50 | oral | 4800mg/kg (4800mg/kg) | "Antibiotics: Origin, Nature, and Properties," Korzyoski, T., et al., eds., Washington, DC, American Soc. for Microbiology, 1978Vol. 1, Pg. 501, 1978. | |
women | TDLo | oral | 24mg/kg/6D-I (24mg/kg) | BLOOD: THROMBOCYTOPENIA | American Journal of Hematology. Vol. 43, Pg. 333, 1993. |